Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo

British Journal of Cancer

Volumn 78, Issue 3, 1998, Pages 296-300

  Barker, K T ^a   Crompton, M R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer; Ras gene; Single strand conformational polymorphism; TC21

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; BREAST CANCER; BREAST CARCINOMA; CODON; DNA SEQUENCE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; METASTASIS; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; ONCOGENE RAS; OVARY CARCINOMA; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; UTERINE CERVIX CANCER;

EID: 0031844181     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.490     Document Type: Article

References (43)

1. Andersen LB, Fountain JW, Gutmann DH, Tarlé SA, Glover TW, Dracopoli NC, Housman DE and Collins FS (1993) Mutations in the neurofibromatosis t gene in sporadic malignant melanoma cell lines. Nature Genet 3: 118-121
2. Andres A-C, Schönenberger C-A, Groner B, Hennighausen L and LeMeur M, Gerlinger P (1987) Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumour induction in transgenic mice, Proc Natl Acad Sci USA 84: 1299-1303
3. Barbacid M (1987) ras genes. Annu Rev Biochem 56: 779-827
4. Barker KT, Martindale JH, Mitchell PJ, Kamalati T, Page MJ, Phippard DJ, Dale TC, Gusterson BA and Crompton MR (1995) Expression patterns of the novel receptor-like tyrosine kinase. DDR. in human breast tumours. Oncogene 10: 569-575
5. Bar-Sagi D, Feramisco JR (1985) Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell 42: 841-848
6. Basolo F, Elliott J, Tait L, Chen XC, Maloney T, Russo IH, Pauley R, Momiki S, Caamano J, Klein-Szanto AJP, Koszalka M and Russo J (1991) Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinogen 4: 25-35
7. Basu TN, Gutmann DH, Fetcher JA, Glover TW, Collins FS and Downward J (1992) Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients. Nature 356: 713-715
8. Berchuck A, Carney M (1997) Human ovarian cancer of the surface epithelium, Biochem Pharmcol 54: 541-544
9. Boguski MS and McCormick F (1993) Proteins regulating Ras and its relatives. Nature 366: 643-654
10. Bollag G, Clapp DW, Shih S, Adler F, Zhang YY, Thompson P, Lange BJ, Freedman MH, McCormick F, Jacks T and Shannon K (1996) Loss of NF 1 results in activation of the Ras signalling pathway and leads to aberrant growth in haematopoietic cells. Nature Genet 12: 144-148
11. Bos JL (1988) The ras gene family and human carcinogenesis. Mater Res 195: 255-271
12. Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Rev 49: 4682-4689
13. Chan AM-L, Miki T, Meyers KA, Aaronson SA (1994) A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. Proc Natl Acad Sci USA 91: 7558-7562
14. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutler WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299
15. Clark GJ and Der CJ (1995) Aberrant function of the Ras signal transduction pathway in human breast cancer, Breast Cancer Res Treat 35: 133-144
16. Clark GJ, Kinch MS, Gilmer TM, Burridge K and Der CJ (1996) Overexpression of the ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. Oncongene 12: 169-176
17. Cuatrecasas M, Villanueva A, Matias-Guiu X and Prat J (1997) K-ras mutations in mucinous ovarian tumors: a clinicopathologic and molecular study of 95 cases. Cancer 79: 1581-1586
18. Ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69: 265-273
19. Drivas GT, Shih A, Coutavas E, Rush MG and D'Eustachio (1990) Characterization of four novel ras-like genes expressed in a human teralocarcinoma cell line. Mol Cell Biol 10: 1793-1798
20. Gioanni J, Le François D, Zanghellini E, Mazeau C, Eltore F, Lambert J-C, Scneider M and Dutrillaux B (1990) Establishment and characterisation of a new tumorigenic cell line with a normal karyotype derived from a human breast adenocarcinoma. Br J Cancer 62: 8-13
21. Graham SM, Cox AD, Drivas G, Rush MG, D'Eustachio P, Der CJ (1994) Aberrant function of the ras-related protein TC21/R-Ras2 triggers malignant transformation. Mol Cel Biol 14: 4108-4115
22. Guha A, Lau N, Huvar I, Gutmann D, Provias J, Pawson T and Boss G (1996) Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene 12: 507-513
23. Huang Y, Saez R, Chao L, Santos E, Aaronson SA and Chan AM-L (1995) A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. Oncogene 11: 1255-1260
24. Ichikawa Y, Nishida M, Suzuki H, Yoshida S, Tsunoda H, Kubo T, Uchida K and Miwa M (1994) Mutation of K-ras protooncogene is assocated with histological subtypes in human mucinous ovarian tumors. Cancer Res 54: 33-35
25. Johnson MR, Look AT, DeClue JE, Valentine MB and Lowy DR (1993) Inactivation of the NF1 gene in human melanoma and neuroblastoma cell lines without impaired regulalton of GTP-RAS Proc Natl Acad Sci USA 90: 5539-5543
26. Legius E, Marchuk DA, Collins FS and Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nature Genet 3: 122-126
27. Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, Friedman E, Samowitz W, Robertson M, Bradley P, McCormick F, While R and Cawthon R (1992) Somatic mutations in the neurofibromatosis 1 gene in human tumors, Cell 69: 275-281
28. Mangues R, Seidman I, Gordon JW and Pellicer A (1992) Overexpression of the N-ras proto-oncogene. not somatic mutational activation, associated with malignant tumors in transgenic mice. Oncogene 7: 2073-2076
29. Marais R and Marshall CJ (1996) Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surverys 27: 101-125
30. Noda M, Ko M, Ogura A, Liu D-g, Amano T, Takano T and Ikawa Y (1985) Sarcoma viruses carrying ras oncogenes induce differentiation-associated properties in a neuronal cell line. Nature 318: 73-75
31. Riou G, Barrois M, Sheng Z-M, Duvillard P and Lhomme C (1988) Somatic deletions and mutations of c-Ha-ras gene in human cervical cancers. Oncogene 3: 329-333
32. Sanger F, Nicklen S and Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74: 5463-5467
33. Sinn E, Muller W, Pattengale P, Tepler J, Wallace R and Leder P (1987) Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo, Cell 49: 465-475
34. Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF and Brooks SC (1990) Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075-6086
35. Sukumar S (1990) An experimental analysis of cancer: role of ras oncogenes in multistep carcinogenesis. Cancer Cells 2: 199-204
36. Teh HT, Birrell G, Farrell A, Leonard JH, Walters MK, Palmer JM, Ramsay JR, Schlect DJ, Furnival C, Lavin MF, Bennett I and Hayward NK (1997) Breast cancer in six women with neurofibromatosis type 1. Breast 6: 155-160
37. Theile M, Hartmann S, Naundorf H, Rueß D, Elbe B, Krause H, Deppert W, Barrett JC and Scherneck S (1994) Wild-type p53 is not involved in reversion of the tumorigenic phenotype of breast cancer cells alter transfer of normal chromosome 17. Int J Oncol 4: 1067-1075
38. van't Veer LJ, Hermens R, van den Berg-Bakker LAM, Ching Cheng N, Fleuren G-J, Bos JL, Cleton FJ and Schrier (1988) ras oncogene activation in human ovarian carcinoma. Oncogene 2: 157-165
39. Watson DMA, Elton RA, Jack WJL, Dixon JM, Chelty U and Miller WR (1990) The H-ras oncogene product p21 and prognosis in human breast cancer. Breast Cancer Res Treat 17: 161-169.
40. Wilkinson M (1988) RNA isolation: a mini-prep method. Nucleic Acids Res 16: 10933
41. Willis G, Jennings B, Ball RY, New NE and Gibson I (1993) Analysis of ras point mutations and human papillomavirus 16 and 18 in cervical carcinomata and their metastases, Gynecol Oncol 49: 359-364
42. Wong YF, Chung TK, Cheung TH, Lam SK, Xu YG and Chang AM (1995) Frequent ras mutations in squamous cell cervical cancer. Cancer Lett 95: 29-32
43. Zhang PL, Calaf G and Russo J (1994) Allele loss and point mutation in codons 12 and 61 of the c-Ha-ras oncogene in carcinogen-transformed human breast epithelial cells. Mol Carcinogen 1: 46-56